Devaki Nair

机构：Royal Free London NHS Foundation Trust, Çevre, Şehircilik ve İklim Değişikliği Bakanlığı · ORCID：0000-0002-4123-0596

发表论文 100 篇 · 总被引 3041 次 · h-index 29

代表论文

• Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP) (2023 · Pharmacological Research · 被引 68)
• Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP) (2021 · Progress in Cardiovascular Diseases · 被引 62)
• Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV (2024 · Journal of clinical lipidology · 被引 54)
• Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study (2021 · PLoS ONE · 被引 29)
• Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes (2026 · JAMA · 被引 17)
• International prevalence patterns of low eGFR in adults aged 18-60 without traditional risk factors from a population-based cross-sectional disadvantaged populations eGFR epidemiology (DEGREE) study (2024 · Kidney International · 被引 17)